| MeSH term | MeSH ID | Detail |
|---|---|---|
| Candidemia | D058387 | 2 associated lipids |
| Aspergillosis | D001228 | 5 associated lipids |
| Blastomycosis | D001759 | 5 associated lipids |
| Xerostomia | D014987 | 6 associated lipids |
| Vaginitis | D014627 | 6 associated lipids |
| Gonorrhea | D006069 | 7 associated lipids |
| Candidiasis, Vulvovaginal | D002181 | 8 associated lipids |
| Otitis Externa | D010032 | 8 associated lipids |
| AIDS-Related Opportunistic Infections | D017088 | 9 associated lipids |
| Urethritis | D014526 | 9 associated lipids |
Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| ZemljiÄ Jokhadar Å et al. | Osmotic Effects Induced by Pore-Forming Agent Nystatin: From Lipid Vesicles to the Cell. | 2016 | PLoS ONE | pmid:27788169 |
| Diaz MC et al. | [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. | 2016 | Rev Esp Quimioter | pmid:27167765 |
| Lyu X et al. | Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. | 2016 | Drug Des Devel Ther | pmid:27042008 |
| Salyer AC et al. | Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen. | 2016 | PLoS ONE | pmid:26919709 |
| Pemberton MN | Nystatin and miconazole: pharmacological and clinical evidence regarding interactions with warfarin. | 2016 | Oral Dis | pmid:27416928 |
| Falcone M et al. | Management of candidemia in patients with Clostridium difficile infection. | 2016 | Expert Rev Anti Infect Ther | pmid:27254270 |
| Serrano-Mollar A et al. | Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis. | 2016 | Chest | pmid:27020420 |
| Fabio CA et al. | Use of photodynamic therapy and chitosan for inactivacion of Candida albicans in a murine model. | 2016 | J. Oral Pathol. Med. | pmid:26991463 |
| Preissner S et al. | Adjuvant antifungal therapy using tissue tolerable plasma on oral mucosa and removable dentures in oral candidiasis patients: a randomised double-blinded split-mouth pilot study. | 2016 | Mycoses | pmid:26932256 |
| Vega F et al. | Concomitant sensitization to inhaled budesonide and oral nystatin presenting as allergic contact stomatitis and systemic allergic contact dermatitis. | 2016 | Cutis | pmid:26919353 |
| Pinto Reis C et al. | Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. | 2016 | Pharm Dev Technol | pmid:25567611 |
| Ellepola AN et al. | Impact of brief exposure to antifungal agents on the post-antifungal effect and hemolysin activity of oral Candida albicans. | 2015 Jul-Aug | J Appl Oral Sci | pmid:26398514 |
| Wittekamp BH et al. | Nystatin versus amphotericin B to prevent and eradicate Candida colonization during selective digestive tract decontamination in critically ill patients. | 2015 | Intensive Care Med | pmid:26459880 |
| Mobasheri M et al. | Solubilization Behavior of Polyene Antibiotics in Nanomicellar System: Insights from Molecular Dynamics Simulation of the Amphotericin B and Nystatin Interactions with Polysorbate 80. | 2015 | Molecules | pmid:26712721 |
| de Castro RD et al. | Antifungal activity and mode of action of thymol and its synergism with nystatin against Candida species involved with infections in the oral cavity: an in vitro study. | 2015 | BMC Complement Altern Med | pmid:26601661 |
| Dewan E et al. | Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India. | 2015 | Hematol Oncol Stem Cell Ther | pmid:26173033 |
| Sasek V | Consequences of Misnomer or Mistakes in Identification of Fungal Species. | 2015 | Int J Med Mushrooms | pmid:26853957 |
| Guerra CM et al. | Duration of prophylaxis against fungal infection in kidney transplant recipients. | 2015 | Prog Transplant | pmid:26645924 |
| Austin N et al. | Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. | 2015 | Cochrane Database Syst Rev | pmid:26497202 |
| Fan S et al. | Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. | 2015 | Mycopathologia | pmid:25416649 |